Podcasts

AUDIO: Reduction in perceived stress triggers migraine


 

NEWS FROM THE AAN 2014 ANNUAL MEETING

PHILADELPHIA – Reduction in perceived stress was found to trigger migraine within a day after the stress abated, according to a study.

Over the course of 3 months, 17 migraineurs (16 women and 1 man) with a median age of 44 years self-reported daily entries describing their migraine experiences; daily and evening activities; and information about menses (if relevant), sleep, alcohol consumption, medication schedules, etc., using an adapted version of the Perceived Stress Scale to rate their stress levels. A self-reported stress scale, developed for the study, asked participants to rate their overall stress level for each day on a scale of 1 (not at all stressful) to 10 (extremely stressful).

A review of the more than 2,000 data entries over a total of 1,015 eligible diary days indicated that the odds ratio of a migraine attack happening within 6, 12, or 18 hours after stress reduction ranged between 1.5 and 1.9 (all P values less than .05). Overall levels of stress per day were not significantly related to migraine attack.

The industry-sponsored study was conducted by a team from the Montefiore Headache Center in New York, which included Dr. Richard Lipton, codirector of the center and professor and vice chair of neurology at Albert Einstein College of MedicineThe results are published online in Neurology (2014;82:1395-1401).

In an audio interview at the annual meeting of the American Academy of Neurology, Dr. Lipton discusses the clinical implications of the study, and he offers recommendations for prophylaxis such as mindfulness meditation and other relaxation techniques.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Recommended Reading

No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge ObGyn
CGRP-targeted migraine prevention drugs succeed in phase II
MDedge ObGyn
Acetazolamide improved vision in patients with high intracranial pressure
MDedge ObGyn
FDA panel not convinced by opiate combination safety
MDedge ObGyn
Topical lidocaine reduces menopausal dyspareunia
MDedge ObGyn
Many migraine patients quit meds by 12 months
MDedge ObGyn
Simple screening tool improves headache management in primary care
MDedge ObGyn
Celebrex cost high in United States, low in Canada
MDedge ObGyn
Longer-term opioid use in workers’ comp cases highest in Louisiana
MDedge ObGyn
Chronic migraine affects education, employment, and income
MDedge ObGyn